CI vs CNC
Cigna and Centene Corporation, both Healthcare
Cigna is the larger company at $74B against $30B. Over the past year CNC returned +103% against -2.2% for CI. The RyuScore puts CI ahead, 73 against 27 out of 100.
| Figure | CI | CNC |
|---|---|---|
| Last close | $282 | $65.37 |
| Market cap | $74B | $30B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 11.7 | n/a |
| Dividend yield | 2.1% | n/a |
| 1-year return | -2.2% | +103% |
| 5-year return | +47% | +3.9% |
| RyuScoresector-relative, 1–10 | 73/100 | 27/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Cigna
Revenue of $72B in Q2 2026, net income $1.9B. Its largest reported line is Network Pharmacy, 50% of the disclosed total.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 52% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.